Joining the NYT Vaccine Tracker list as a Phase 1 vaccine would get us a lot more than an "honorable mention" in the preclinical section of "Other protein-based vaccines".

NYT Covid-19 Vaccine Tracker:
https://www.nytimes.com/interactive/2020/scie...acker.html